Part of it, as my deputy is indicating as well, is that there are collaborations we do with other regulatory authorities in other jurisdictions, such as the FDA, for instance, in the United States. Part of it has to do with finding ways to not reinvent the wheel. If there has been, in our estimation, adequate scientific review of certain aspects of an application and if we make the determination in the interests of Canada that this can be part of our process, then it's something we are interested in pursuing.
That's part of the answer, but are there others, Deputy?